166 related articles for article (PubMed ID: 26029998)
1. Dragon (repulsive guidance molecule b, RGMb) is a novel gene that promotes colorectal cancer growth.
Shi Y; Chen GB; Huang XX; Xiao CX; Wang HH; Li YS; Zhang JF; Li S; Xia Y; Ren JL; Guleng B
Oncotarget; 2015 Aug; 6(24):20540-54. PubMed ID: 26029998
[TBL] [Abstract][Full Text] [Related]
2. Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells.
Shi Y; Huang XX; Chen GB; Wang Y; Zhi Q; Liu YS; Wu XL; Wang LF; Yang B; Xiao CX; Xing HQ; Ren JL; Xia Y; Guleng B
Oncotarget; 2016 Jul; 7(30):48027-48037. PubMed ID: 27384995
[TBL] [Abstract][Full Text] [Related]
3. Repulsive guidance molecules, novel bone morphogenetic protein co-receptors, are key regulators of the growth and aggressiveness of prostate cancer cells.
Li J; Ye L; Kynaston HG; Jiang WG
Int J Oncol; 2012 Feb; 40(2):544-50. PubMed ID: 22076499
[TBL] [Abstract][Full Text] [Related]
4. Dragon (repulsive guidance molecule RGMb) inhibits E-cadherin expression and induces apoptosis in renal tubular epithelial cells.
Liu W; Li X; Zhao Y; Meng XM; Wan C; Yang B; Lan HY; Lin HY; Xia Y
J Biol Chem; 2013 Nov; 288(44):31528-39. PubMed ID: 24052264
[TBL] [Abstract][Full Text] [Related]
5. Dragon (repulsive guidance molecule b) inhibits IL-6 expression in macrophages.
Xia Y; Cortez-Retamozo V; Niederkofler V; Salie R; Chen S; Samad TA; Hong CC; Arber S; Vyas JM; Weissleder R; Pittet MJ; Lin HY
J Immunol; 2011 Feb; 186(3):1369-76. PubMed ID: 21187450
[TBL] [Abstract][Full Text] [Related]
6. DRAGON, a GPI-anchored membrane protein, inhibits BMP signaling in C2C12 myoblasts.
Kanomata K; Kokabu S; Nojima J; Fukuda T; Katagiri T
Genes Cells; 2009 Jun; 14(6):695-702. PubMed ID: 19422419
[TBL] [Abstract][Full Text] [Related]
7. Localization and action of Dragon (repulsive guidance molecule b), a novel bone morphogenetic protein coreceptor, throughout the reproductive axis.
Xia Y; Sidis Y; Mukherjee A; Samad TA; Brenner G; Woolf CJ; Lin HY; Schneyer A
Endocrinology; 2005 Aug; 146(8):3614-21. PubMed ID: 15890774
[TBL] [Abstract][Full Text] [Related]
8. Tumour angiogenesis and repulsive guidance molecule b: a role in HGF- and BMP-7-mediated angiogenesis.
Sanders AJ; Ye L; Li J; Mason MD; Jiang WG
Int J Oncol; 2014 Sep; 45(3):1304-12. PubMed ID: 24970050
[TBL] [Abstract][Full Text] [Related]
9. Repulsive guidance molecule B (RGMB) plays negative roles in breast cancer by coordinating BMP signaling.
Li J; Ye L; Sanders AJ; Jiang WG
J Cell Biochem; 2012 Jul; 113(7):2523-31. PubMed ID: 22415859
[TBL] [Abstract][Full Text] [Related]
10. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
12. Repulsive Guidance Molecule b (RGMb) Is Dispensable for Normal Gonadal Function in Mice.
Meng C; Liu W; Huang H; Wang Y; Chen B; Freeman GJ; Schneyer A; Lin HY; Xia Y
Biol Reprod; 2016 Apr; 94(4):78. PubMed ID: 26911425
[TBL] [Abstract][Full Text] [Related]
13. Repulsive guidance molecule b inhibits renal cyst development through the bone morphogenetic protein signaling pathway.
Liu J; Wang W; Liu M; Su L; Zhou H; Xia Y; Ran J; Lin HY; Yang B
Cell Signal; 2016 Dec; 28(12):1842-1851. PubMed ID: 27575743
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.
Ye Y; Xiao L; Wang SJ; Yue W; Yin QS; Sun MY; Xia W; Shao ZY; Zhang H
Oncotarget; 2016 Jan; 7(4):3921-33. PubMed ID: 26646797
[TBL] [Abstract][Full Text] [Related]
16. Scutellaria Barbata D Don Inhibits Colorectal Cancer Growth via Suppression of Multiple Signaling Pathways.
Lin J; Chen Y; Cai Q; Wei L; Zhan Y; Shen A; Sferra TJ; Peng J
Integr Cancer Ther; 2014 May; 13(3):240-8. PubMed ID: 24231788
[TBL] [Abstract][Full Text] [Related]
17. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
18. miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway.
Wang H; An H; Wang B; Liao Q; Li W; Jin X; Cui S; Zhang Y; Ding Y; Zhao L
Eur J Cancer; 2013 Dec; 49(18):3924-35. PubMed ID: 23968734
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Wang Y; Tang Q; Li M; Jiang S; Wang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
[TBL] [Abstract][Full Text] [Related]
20. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
